4,028
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

A critical review of the 2020 EPA risk assessment for chrysotile and its many shortcomings

, , &
Pages 509-539 | Received 30 Apr 2021, Accepted 11 Aug 2021, Published online: 15 Oct 2021

References

  • American Conference of Governmental Industrial Hygienists (ACGIH). 1978. Threshold limit values for chemical substances and physical agents in the workroom environment with intended changes for 1978. Cincinnati (OH): American Conference of Governmental Industrial Hygienists.
  • Agudo A, González CA, Bleda MJ, Ramírez J, Hernández S, López F, Calleja A, Panadès R, Turuguet D, Escolar A, et al. 2000. Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain. Am J Ind Med. 37(2):159–168.
  • Aguilar‐Madrid G, Robles‐Pérez E, Juárez‐Pérez CA, Alvarado‐Cabrero I, Rico‐Méndez FG, Javier KG. 2010. Case–control study of pleural mesothelioma in workers with social security in Mexico. Am J Ind Med. 53:241–251.
  • Alberg AJ, Samet JM. 2003. Epidemiology of lung cancer. Chest. 123(1 Suppl):21S–49S.
  • Anderson AE. 1973. Asbestos fiber emissions during brake servicing. Internal Ford Memo to J.R. Knauss. Dearborn (MI): Mechanical Research Department, Ford Motor Company.
  • Anderson AE, Gealer RL, Mccune RC, Sprys JW. 1973. Asbestos emissions from brake dynamometer tests. Detroit (MI): National Automobile Engineering Meeting.
  • ATSDR. 2002. Expert panel on health effects of asbestos and Synthetic Vitreous Fibers (SVF): the influence of fiber length. New York (NY): Division of Health Assessment & Consultation - Agency for Toxic Substances and Disease Registry.
  • Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. 2018. Malignant mesothelioma and its non-asbestos causes. Arch Pathol Lab Med. 142(6):753–760.
  • Barlow CA, Grespin M, Best EA. 2017. Asbestos fiber length and its relation to disease risk. Inhal Toxicol. 29(12–14):541–554.
  • Barlow CA, Lievense L, Gross S, Ronk CJ, Paustenbach DJ. 2013. The role of genotoxicity in asbestos-induced mesothelioma: an explanation for the differences in carcinogenic potential among fiber types. Inhal Toxicol. 25(9):553–567.
  • Baumann F, Carbone M. 2016. Environmental risk of mesothelioma in the United States: an emerging concern – epidemiological issues. J Toxicol Environ Health B. 19(5–6):231–249.
  • Beckett EM, Miller E, Pierce JS, Finley B. 2020. Comments on the toxic substances control act draft risk evaluation for asbestos docket No. EPA‐HQ‐OPPT‐2019‐0501. Washington (DC): Comments Submitted By Cardno ChemRisk, San Francisco, California.
  • Benhamou S, Benhamou E, Flamant R. 1988. Occupational risk factors of lung cancer in a French case-control study. Occup Environ Med. 45(4):231–233.
  • Berman DW, Crump KS. 2003. Technical support document for a protocol to assess asbestos-related risk. Washington (DC): Environmental Protection Agency.
  • Berman DW, Crump KS. 2008a. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol. 38(sup1):49–73.
  • Berman DW, Crump KS. 2008b. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 38(sup1):1–47.
  • Bernstein D, Dunnigan J, Hesterberg T, Brown R, Velasco JAL, Barrera R, Hoskins J, Gibbs A. 2013. Health risk of chrysotile revisited. Crit Rev Toxicol. 43(2):154–183.
  • Bernstein DM. 2005. Understanding chrysotile asbestos: a new perspective based upon current data. 6th International Scientific Conference. Pilanesberg National Park (South Africa): International Occupational Hygiene Association (IOHA).
  • Bernstein DM. 2014. The health risk of chrysotile asbestos. Curr Opin Pulm Med. 20(4):366–370.
  • Bernstein DM, Hoskins JA. 2006. The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol. 45(3):252–264.
  • Bernstein DM, Rogers R, Smith P. 2003. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhalation Toxicol. 15(13):1247–1274.
  • Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2010. The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results. Inhal Toxicol. 22(11):937–962.
  • Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE. 2011. Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol. 23(7):372–391.
  • Bernstein DM, Rogers RA, Sepulveda R, Kunzendorf P, Bellmann B, Ernst H, Creutzenberg O, Phillips JI. 2015. Evaluation of the fate and pathological response in the lung and pleura of brake dust alone and in combination with added chrysotile compared to crocidolite asbestos following short-term inhalation exposure. Toxicol Appl Pharmacol. 283(1):20–34.
  • Bernstein DM, Toth B, Rogers RA, Kling DE, Kunzendorf P, Phillips JI, Ernst H. 2020a. Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO2, chrysotile, crocidolite or amosite asbestos in a 90-day quantitative inhalation toxicology study – Interim results Part 2: histopathological examination, confocal microscopy and collagen quantification of the lung and pleural cavity. Toxicol Appl Pharmacol. 387:114847.
  • Bernstein DM, Toth B, Rogers RA, Kling DE, Kunzendorf P, Phillips JI, Ernst H. 2020b. Evaluation of the exposure, dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO2, chrysotile, crocidolite or amosite asbestos in a 90-day quantitative inhalation toxicology study – interim results Part 1: experimental design, aerosol exposure, lung burdens and BAL. Toxicol Appl Pharmacol. 387:114856.
  • Bernstein DM, Toth B, Rogers RA, Kunzendorf P, Phillips JI, Schaudien D. 2021. Final results from a 90-day quantitative inhalation toxicology study evaluating the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO2, chrysotile, crocidolite or amosite asbestos: histopathological examination, confocal microscopy and collagen quantification of the lung and pleural cavity. Toxicol Appl Pharmacol. 424:115598.
  • Bernstein DM, Toth B, Rogers RA, Sepulveda R, Kunzendorf P, Phillips JI, Ernst H. 2018. Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to chrysotile or crocidolite asbestos in a 28-day quantitative inhalation toxicology study. Toxicol Appl Pharmacol. 351:74–92.
  • Berrington DE Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E. 2010. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer. 102(1):220–226.
  • Berry G, Newhouse ML, Antonis P. 1985. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br J Ind Med. 42(1):12–18.
  • Blake CL, VAN Orden DR, Banasik M, Harbison RD. 2003. Airborne asbestos concentration from brake changing does not exceed permissible exposure limit. Regul Toxicol Pharm. 38(1):58–70.
  • Boelter FW, Spencer JW, Simmons CE. 2007. Heavy equipment maintenance exposure assessment: using a time-activity model to estimate surrogate values for replacement of missing data. J Occup Environ Hyg. 4(7):525–537.
  • Borre LVD, Deboosere P. 2015. Enduring health effects of asbestos use in Belgian industries: a record-linked cohort study of cause-specific mortality (2001–2009). BMJ Open. 5(6):e007384.
  • Boyles MSP, Poland CA, Raftis J, Duffin R. 2019. Assessment of the physicochemical properties of chrysotile-containing brake debris pertaining to toxicity. Inhal Toxicol. 31(8):325–342.
  • Brenner J, Sordillo PP, Magill GB. 1981. Malignant mesothelioma in children: report of seven cases and review of the literature. Med Pediatr Oncol. 9(4):367–373.
  • Brooks R. 2020. RE: toxic substances control act Science Advisory Committee on Chemicals (SACC) peer review, Docket Number: EPA-HQ-OPPT-2019-0501. Washington (DC): Comments submitted by The Chlorine Institute.
  • Brzeziańska E, Dutkowska A, Antczak A. 2013. The significance of epigenetic alterations in lung carcinogenesis. Mol Biol Rep. 40(1):309–325.
  • Bueno R, Stawiski EW, Goldstein LD, Durinck S, Rienzo AD, Modrusan Z, Gnad F, Nguyen TT, Jaiswal BS, Chirieac LR, et al. 2016. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 48(4):407–416.
  • Burdorf A, Heederik D. 2011. Applying quality criteria to exposure in asbestos epidemiology increases the estimated risk. Ann Occup Hyg. 55(6):565–568.
  • Carbone M. 2020. EPA document # EPA-740-R1-8012 - asbestos; draft Toxic Substances Control Act (TSCA) risk evaluation and TSCA Science Advisory Committee on Chemicals (SACC) meetings. Washington (DC): Comments submitted by The Cancer Center – University of Hawai’i.
  • Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐Bosco E, Galateau‐Salle F, Jablons D, et al. 2019. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J Clin. 69:402–429.
  • Cardarelli JJ, Ulsh BA. 2018. It is time to move beyond the linear no-threshold theory for low-dose radiation protection. Dose-Res Internat J. 16(3).
  • Carthew P, Hill RJ, Edwards RE, Lee PN. 1992. Intrapleural administration of fibres induces mesothelioma in rats in the same relative order of hazard as occurs in man after exposure. Hum Exp Toxicol. 11(6):530–534.
  • Casalone E, Allione A, Viberti C, Pardini B, Guarrera S, Betti M, Dianzani I, Aldieri E, Matullo G. 2018. DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos response. Arch Toxicol. 92(5):1785–1795.
  • Case B. 2020. Case BW comments on US EPA draft risk evaluation for asbestos, dated March 2020 (EPA Document # EPA-740-R1-8012). Washington (DC): Comments submitted by The Department of Pathology, McGill University, Montreal, Canada.
  • Case BW, Dufresne A, Mcdonald AD, Mcdonald JC, Sébastien P. 2000. Asbestos fiber type and length in lungs of chrysotile textile and production workers: fibers longer than 18 μm. Inhalation Toxicol. 12(sup3):411–418.
  • Cha S, Carter P, Bradow RL. 1983. Simulation of automobile brake wear dynamics and estimation of emissions. Dearborn (MI): Passenger Car Meeting & Exposition; 831036.
  • Chang ET, Lau EC, Mowat FS, Teta MJ. 2017. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma. Cancer Causes Control. 28(9):971–979.
  • Christensen BC, Houseman EA, Godleski JJ, Marsit CJ, Longacker JL, Roelofs CR, Karagas MR, Wrensch MR, Yeh R-F, Nelson HH, et al. 2009. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res. 69(1):227–234.
  • Churg A. 1998. Neoplastic asbestos-induced disease. In: Pathology of occupational lung disease. Baltimore (MD): Williams & Wilkins.
  • Clements M, Berry G, Shi J, Ware S, Yates D, Johnson A. 2007. Projected mesothelioma incidence in men in New South Wales. Occup Environ Med. 64(11):747–752.
  • Commerce USCO. 2020. Re: draft risk evaluation for asbestos: docket EPA-HQ-OPPT-2019-0501. Washington (DC): United States Department of Commerce.
  • Consonni D, Matteis SD, Lubin JH, Wacholder S, Tucker M, Pesatori AC, Caporaso NE, Bertazzi PA, Landi MT. 2010. Lung cancer and occupation in a population-based case-control study. Am J Epidemiol. 171(3):323–333.
  • Cooper T, Sheehy J, O'Brien D, Mcglothlin J, Todd W. 1987. n-depth survey report: evaluation of brake drum service controls at United States postal service vehicle maintenance facility, Louisville, Kentucky, Report No. CT-152-11B. Washington (DC): National Institute for Occupational Safety and Health.
  • Cooper T, Sheehy J, O'Brien D, Mcglothlin J, Todd W. 1988. In-depth survey report: evaluation of brake drum service controls at Cincinnati Gas and Electric Garages, Cincinnati, Evanston, and Monroe, Ohio and Covington, Kentucky (ECTB 152-22b). Cincinnati (OH): National Institute for Occupational Safety and Health.
  • Corbin M, McLean D, Mannetje A', Dryson E, Walls C, McKenzie F, Maule M, Cheng S, Cunningham C, Kromhout H, et al. 2011. Lung cancer and occupation: a New Zealand cancer registry-based case-control study. Am J Ind Med. 54(2):89–101.
  • Cossette M, Delvaux P. 1979. Technical evaluation of chrysotile asbestos ore bodies. In Short course in mineralogical techniques of asbestos determination. Vol. 4;. Ottawa (ON): Mineralogical Association of Canada; p. 79–109.
  • Cowan DM, Cheng TJ, Ground M, Sahmel J, Varughese A, Madl AK. 2015. Analysis of workplace compliance measurements of asbestos by the U.S. Occupational Safety and Health Administration (1984–2011). Regul Toxicol Pharmacol. 72(3):615–629.
  • Cree M, Lalji M, Jiang B, Carriere KC, Beach J, Kamruzzaman A. 2009. Explaining Alberta’s rising mesothelioma rates. Chronic Dis Can. 29(4):144–152.
  • Davis JMG, Coniam SW. 1973. Experimental studies on the effects of heated chysotile asbestos and automobile brake lining dust injected ino the body cavities of mice. Exp Mol Pathol. 19(3):339–353.
  • De Bruin ML, Burgers JA, Baas P, Van't Veer MB, Noordijk EM, Louwman MWJ, Zijlstra JM, Van Den Berg H, Aleman BMP, Van Leeuwen FE. 2009. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood. 113(16):3679–3681.
  • DE Klerk NH, Musk AW, Williams V, Filion PR, Whitaker D, Shilkin KB. 1996. Comparison of measures of exposure to asbestos in former crocidolite workers from Wittenoom Gorge, W. Australia. Am J Ind Med. 30(5):579–587.
  • Dement JM. 1972. Cincinnati municipal garage - automobile brake servicing operation. U.S.P.H.S. Survey. Bethesda (MD): United States Public Health Service.
  • Dement JM. 2020. Comments on EPA Draft Asbestos Risk Assessment, March 2020. Durham (NC): Duke University School of Medicine.
  • Dement JM, Loomis D, Richardson D, Wolf SH, Kuempel ED. 2011. Estimates of historical exposures by phase contrast and transmission electron microscopy for pooled exposure–response analyses of North Carolina and South Carolina, USA asbestos textile cohort. Occup Environ Med. 68:593–598.
  • Dement JM, Brown DP, Okun A. 1994. Follow-up study of chrysotile asbestos textile workers: cohort mortality and case-control analyses. Am J Ind Med. 26(4):431–447.
  • Dement JM, Myers D, Loomis D, Richardson D, Wolf S. 2009. Estimates of historical exposures by phase contrast and transmission electron microscopy in North Carolina USA asbestos textile plants. Occup Environ Med. 66(9):574–583.
  • Deutsch M, Land SR, Begovic M, Cecchini R, Wolmark N. 2007. An association between postoperative radiotherapy for primary breast cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) studies and the subsequent appearance of pleural mesothelioma. Am J Clin Oncol. 30(3):294–296.
  • Eastern Research Group I. 2003a. Report on the expert panel on health effects of asbestos and synthetic vitreous fibers: the influence of fiber length. Atlanta (GE): Agency for Toxic Substances and Disease Registry – Division of Health Assessment and Consultation.
  • Eastern Research Group I. 2003b. Report on the peer consultation workshop to discuss a proposed protocol to assess asbestos-related risk. Washington (DC): U.S. Environmental Protection Agency - Office of Solid Waste and Emergency Response.
  • Elliott L, Loomis D, Dement J, Hein MJ, Richardson D, Stayner L. 2012. Lung cancer mortality in North Carolina and South Carolina chrysotile asbestos textile workers. Occup Environ Med. 69(6):385–390.
  • EPA. 1986. Airborne Asbestos Health Assessment Update. Office of Health and Environmental Assessment. https://nepis.epa.gov/Exe/ZyNET.exe/20009EBT.TXT?ZyActionD=ZyDocument&Client=EPA&Index=1981+Thru+1985&Docs=&Query=&Time=&EndTime=&SearchMethod=1&TocRestrict=n&Toc=&TocEntry=&QField=&QFieldYear=&QFieldMonth=&QFieldDay=&IntQFieldOp=0&ExtQFieldOp=0&XmlQuery=&File=D%3A%5Czyfiles%5CIndex%20Data%5C81thru85%5CTxt%5C00000002%5C20009EBT.txt&User=ANONYMOUS&Password=anonymous&SortMethod=h%7C-&MaximumDocuments=1&FuzzyDegree=0&ImageQuality=r75g8/r75g8/x150y150g16/i425&Display=hpfr&DefSeekPage=x&SearchBack=ZyActionL&Back=ZyActionS&BackDesc=Results%20page&MaximumPages=1&ZyEntry=1&SeekPage=x&ZyPURL
  • EPA. 2005. Guidelines for Carcinogen Risk Assessment. Washington, DC: Risk Assessment Forum - U.S. Environmental Protection Agency.
  • EPA. 2014. Toxicological review of Libby amphibole asbestos. Integrated Risk Information System, National Center for Environmental Assessment. https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=292394
  • EPA. 2016. Summary of the toxic substances control Act. 15 U.S.C. §2601 et seq. (1976). https://www.epa.gov/laws-regulations/summary-toxic-substances-control-act
  • EPA. 2020a. Draft risk evaluation for asbestos. Office of Chemical safety and Pollution Prevention. Washington (DC): Environmental Protection Agency. https://www.regulations.gov/document/EPA-HQ-OPPT-2019-0501-0002
  • EPA. 2020b. Risk evaluation for asbestos, Part I: chrysotile asbestos. Office of Chemical safety and Pollution Prevention. Washington (DC): Environmental Protection Agency. https://www.epa.gov/sites/default/files/2020-12/documents/1_risk_evaluation_for_asbestos_part_1_chrysotile_asbestos.pdf
  • EPA. 2020c. Summary of external peer review and public comments for asbestos and disposition for asbestos part 1: chrysotile asbestos – response to support risk evaluation for asbestos part I: chrysotile asbestos.. Washington (DC): Environmental Protection Agency. https://www.epa.gov/sites/default/files/2020-12/documents/2_summary_of_external_peer_review_and_public_comments_and_disposition.pdf
  • EPA. 2020d. Transmittal of meeting minutes and final report for the TSCA science advisory committee on chemicals meeting via phone and webcast held June 8–11, 2020.. Washington (DC): Environmental Protection Agency. https://cfpub.epa.gov/si/si_public_file_download.cfm?p_download_id=541492&Lab=OPPT
  • EPA. 2021. EPA commits to strengthening science used in chemical risk evaluations. Washington (DC): Environmental Protection Agency. https://www.epa.gov/newsreleases/epa-commits-strengthening-science-used-chemical-risk-evaluations
  • Erren TC, Jacobsen M, Piekarski C. 1999. Synergy between asbestos and smoking on lung cancer risks. Epidemiology. 10(4):405–411.
  • Farioli A, Violante FS, Mattioli S, Curti S, Kriebel D. 2013. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control. 24(8):1535–1545.
  • Ferrante D, Mirabelli D, Silvestri S, Azzolina D, Giovannini A, Tribaudino P, Magnani C. 2020. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: a cohort study. Am J Ind Med. 63(2):135–145.
  • Finkelstein MM. 2021. Supplemented January 12, 2021 after Review of EPA December 2020 chrysotile reports. Toronto (ON): University of Toronto.
  • Finkelstein MM, Dufresne A. 1999. Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers. Am J Ind Med. 35(4):401–412.
  • Finley BL, Richter RO, Mowat FS, Mlynarek S, Paustenbach DJ, Warmerdam JM, Sheehan PJ. 2007. Cumulative asbestos exposure for US automobile mechanics involved in brake repair (circa 1950s–2000). J Expo Sci Environ Epidemiol. 17(7):644–655.
  • FOIA. 2021. FOIA request for information relating to: peer review of EPA draft risk evaluation of asbestos dated June 8–11, 2020.
  • Fraire AE, Cooper S, Greenberg SD, Buffler P, Langston C. 1988. Mesothelioma of childhood. Cancer. 62(4):838–847.
  • Fraire AE, Greenberg SD, Spjut HJ, Dodson RF, Williams G, Lach-Pasko E, Roggli VL. 1997. Effect of erionite on the pleural mesothelium of the Fischer 344 rat. Chest. 111(5):1375–1380.
  • Frank AL. 2017. Frank Arthur Deposition – Exhibit 5 - 5/15/17.
  • Garabrant D. 2020. Comments on US EPA office of chemical safety and pollution prevention and toxics draft risk evaluation for asbestos, dated march 2020 (EPA Document # EPA-740-R1-8012). Washington (DC): Comments submitted by The University of Michigan, Ann Arbor, Michigan.
  • Garabrant DH, Alexander DD, Miller PE, Fryzek JP, Boffetta P, Teta MJ, Hessel PA, Craven VA, Kelsh MA, Goodman M. 2016. Mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. ANNHYG. 60(8):1036–1026.
  • Garabrant DH, Pastula ST. 2018. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol. 361:127–136.
  • Gibb H, Fulcher K, Nagarajan S, Mccord S, Fallahian NA, Hoffman HJ, Haver C, Tolmachev S. 2013. Analyses of radiation and mesothelioma in the US transuranium and uranium registries. Am J Public Health. 103(4):710–716.
  • Girardi P, Bressan V, Merler E. 2014. ast trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region. Cancer Epidemiol. 38(5):496–503.
  • Godbey F, Cooper T, Sheehy J, O'Brien D, VAN Wagenen H, Mcglothlin J, Todd W. 1987. n-Depth survey report: evaluation of brake drum service controls at United States Postal Service, Vehicle Maintenance Facility, Nashville, Tennessee. Washington (DC): National Institute for Occupational Safety and Health. Report No. CT-152-20B.
  • Golden R. 2019. Dedication and prologue. Chem Biol Interact. 301:1.
  • Golden R, Bus J, Calabrese E. 2019. An examination of the linear no-threshold hypothesis of cancer risk assessment: introduction to a series of reviews documenting the lack of biological plausibility of LNT. Chem Biol Interact. 301:2–5.
  • Goodman JE, Dodge DG, Bailey LA, Prueitt RL, Peterson MK, Beck BD, Engel AM. 2020. Comments on the toxic substances control act draft risk evaluation for asbestos regarding chrysotile asbestos and the occupational use of automotive brakes. Washington (DC): Comments submitted by Gradient.
  • Goodman JE, Nascarella MA, Valberg PA. 2009. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control. 20(8):1237–1254.
  • Goodman M, Teta MJ, Hessel PA, Garabrant DH, Craven VA, Scrafford CG, Kelsh MA. 2004. Mesothelioma and lung cancer among motor vehicle mechanics: a meta-analysis. Ann Occup Hyg. 48(4):309–326.
  • Green FH, Harley R, Vallyathan V, Althouse R, Fick G, Dement J, Mitha R, Pooley F. 1997. Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. Occup Environ Med. 54(8):549–559.
  • Guida F, Papadopoulos A, Menvielle G, Matrat M, Févotte J, Cénée S, Cyr D, Schmaus A, Carton M, Paget-Bailly S, et al. 2011. Risk of lung cancer and occupational history: results of a French population-based case-control study, the ICARE study. J Occup Environ Med. 53(9):1068–1077.
  • Gustavsson P, Plato N, Lidstrom E-B, Hogstedt C. 1990. Lung cancer and exposure to diesel exhaust among bus garage workers. Scand J Work Environ Health. 16(5):348–354.
  • Hammond EC, Selikoff IJ, Seidman H. 1979. Asbestos exposure, cigarette smoking and death rates. Ann N Y Acad Sci. 330:473–790.
  • Hamra GB, Richardson DB, Dement J, Loomis D. 2017. Lung cancer risk associated with regulated and unregulated chrysotile asbestos fibers. Epidemiology. 28:275–280.
  • Hansen ES. 1989. Mortality of auto mechanics: a ten-year follow-up. Scand J Work Environ Health. 15(1):43–46.
  • Hansen J, Tinggaard M, Meersohn A. 2003. Kraeftsygelighed (1970-97) blandt danske lønmodtagere fordelt på Arbejdstilsynets 49 branchegrupper. Nykobing (Denmark): Institut for Epidemiologisk Kraeftforskning, 123.
  • Hardin BD. 2020. Comment on draft risk evaluation for asbestos, EPA Document # EPA-740-R1-8012 in Docket EPA-HP-OPPT-2019-0501. Washington (DC): Comments submitted by JS Held.
  • Hatch D. 1970. Possible alternatives to asbestos as a friction material. Ann Occup Hyg. 13:25–29.
  • Hein MJ, Stayner LT, Lehman E, Dement JM. 2007. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med. 64(9):616–624.
  • Hessel PA, Teta MJ, Goodman M, Lau E. 2004. Mesothelioma among brake mechanics: an expanded analysis of a case-control study. Risk Anal. 24(3):547–552.
  • Hesterberg TW, Hart GA, Chevalier J, Miiller WC, Hamilton RD, Bauer J, Thevenaz P. 1998. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCFI, and chrysotile asbestos in rats. Toxicol Appl Pharmacol. 153(1):68–82.
  • Hickish DE, Knight KL. 1970. Exposure to asbestos during brake maintenance. Ann Occup Hyg. 13:17–21.
  • Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman D, Tarpey P, Danilova L, Drill E, Gibb EA, et al. 2018. Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov. 8(12):1548–1565.
  • Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, et al. 2007. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. JCO. 25(12):1489–1497.
  • Holstein EC. 2021. Re: Robie Walls litigation. Belmont (MA): MS Consulting.
  • Hrubec A, Blair AE, Vaught J. 1995. Mortality risks by industry among US veterans of known smoking status: 1954–1980. NIH Publication No. 95-2747. In: US Department of Health and Human Services (DHHS), P. H. S., National Institutes of Health (NIH) (ed). Washington (DC): National Institutes of Health (NIH).
  • Hrubec Z, Blair AE, Rogot E, Vaught J. 1992. Mortality risks by occupation among US veterans of known smoking status: 1954–1980. NIH Publication No. 92-3407. In: US Department of Health and Human Services (DHHS), P. H., Servicenational Institutes of Health (NIH) (ed.). Washington (DC): National Institutes of Health (NIH).
  • HSS USDOHAHS. 2020. Smoking cessation: a report of the surgeon general. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
  • Huang SX, Jaurand M-C, Kamp DW, Whysner J, Hei TK. 2011a. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B. 14(1–4):179–245.
  • Huang SXL, Jaurand M-C, Kamp DW, Whysner J, Hei TK. 2011b. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B. 14(1–4):179–245.
  • Huncharek M. 2002. Non-asbestos related diffuse malignant mesothelioma. Tumori. 88(1):1–9.
  • Hylebos M, Camp GV, Meerbeeck JPV, Beeck KOD. 2016. The genetic landscape of malignant pleural mesothelioma: results from massively parallel sequencing. J Thorac Oncol. 11(10):1615–1626.
  • In re W.R. Grace & Co., B. R., 482 (BANKR. D. DEL. 2006). 2007. (“Dr. Anderson’s analysis is unreliable. Dr. Anderson’s opinion, therefore, does not satisfy Daubert and its progeny and is not admissible. We exclude this evidence.”), appeal denied, 2007 WL 1074094 (D. Del. Mar. 26, 2007).
  • Jacko MG, Ducharme RT, Somers JH. 1973. Brake and clutch emissions generated during vehicle operation. Proceedings of the Automobile Engineering Meeting, 1973-02-01. 20.
  • Järvholm B, Brisman J. 1988. Asbestos associated tumours in car mechanics. Br J Ind Med. 45:645–646.
  • Jaurand MC, Bignon J, Sebastien P, Goni J. 1977. Leaching of chrysotile asbestos in human lungs. Environ Res. 14(2):245–254.
  • Johnson NF, Edwards RE, Munday DE, Rowe N, Wagner JC. 1984. Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats. Br J Exp Pathol. 65(3):377–388.
  • Johnson P, Zumwalde RD, Roberts D. 1979. Industrial hygeine assessment of seven brake servicing facilities. industrial hygeine section. Concinatti (OH): National Institute for Occupational Safety and Health.
  • Kamp DW, Weitzman SA. 1999. The molecular basis of asbestos induced lung injury. Thorax. 54(7):638–652.
  • Kanbay A, Simsek ZO, Tutar N, Yilmaz I, Buyukoglan H, Canoz O, Demir R. 2014. Non-asbestos-related malignant pleural mesothelioma. Intern Med. 53(17):1977–1979.
  • Kayatta MO, Dineen SP, Sica G, Puskas JD, Pickens A. 2013. Primary pericardial mesothelioma in a 19-year-old presenting as pericarditis. Ann Thorac Surg. 96(2):680–681.
  • Kopylev L, Sullivan PA, Vinikoor LC, Bateson TF. 2011. Monte Carlo analysis of impact of underascertainment of mesothelioma cases on underestimation of risk. TOEPIJ. 4(1):45–53.
  • Korchevskiy A, Rasmuson JO, Rasmuson EJ. 2019. Empirical model of mesothelioma potency factors for different mineral fibers based on their chemical composition and dimensionality. Inhal Toxicol. 31(5):180–191.
  • LA Vecchia C, Decarli A, Peto J, Levi F, Tomei F, Negri E. 2000. An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev. 9:179–184.
  • Lacourt A, Gramond C, Rolland P, Ducamp S, Audignon S, Astoul P, Chamming'S S, Gilg Soit Ilg A, Rinaldo M, Raherison C, et al. 2014. Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma. Thorax. 69(6):532–539.
  • Lacquet LM, VAN DER Linden L. 1980. Roentgenographic lung changes, asbestosis and mortality in a Belgian asbestos-cement factory. Biological effects of mineral fibres. Lyon (France): International Agency for Research on Cancer.
  • Langer AM. 2003. Reduction of the biological potential of chrysotile asbestos arising from conditions of service on brake pads. Regul Toxicol Pharmacol. 38(1):71–77.
  • Lemen RA. 2020. Comments of Richard A. Lemen, Ph.D., MSPH on EPA’s Draft Risk Evaluation for Asbestos 27 May 2020. Washington (DC). https://www.regulations.gov/document/EPA-HQ-OPPT-2019-0501-0057
  • Lenters V, Burdorf A, Vermeulen R, Stayner L, Heederik D. 2012. Quality of evidence must guide risk assessment of asbestos. Ann Occup Hyg. 56(8):879–887.
  • Lerchen ML, Wiggins CL, Samet JM. 1987. Lung cancer and occupation in New Mexico. J Natl Cancer Inst. 79(4):639–645.
  • Liddell FDK, Armstrong B. 2002. The combination of effects on lung cancer of cigarette smoking and exposure in Quebec chrysotile miners and millers. Ann Occup Hyg. 46(1):5–13.
  • Liddell FDK, McDonald AD, McDonald JC. 1997. The 1891–1920 birth cohort of Quebec chrysotile miners and millers: development from 1904 and mortality to 1992. Ann Occup Hyg. 41(1):13–36.
  • Lippmann M. 1988. Asbestos exposure indices. Environ Res. 46(1):86–106.
  • Lippmann M. 2014. Toxicological and epidemiological studies on effects of airborne fibers: coherence and public [corrected] health implications. Crit Rev Toxicol. 44(8):643–695.
  • Loomis D, Dement J, Richardson D, Wolf S. 2010. Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med. 67(9):580–584.
  • Loomis D, Dement JM, Elliott L, Richardson D, Kuempel ED, Stayner L. 2012. Increased lung cancer mortality among chrysotile asbestos textile workers is more strongly associated with exposure to long thin fibres. Occup Environ Med. 69(8):564–568.
  • Loomis D, Dement JM, Wolf SH, Richardson DB. 2009. Lung cancer mortality and fibre exposures among North Carolina asbestos textile workers. Occup Environ Med. 66(8):535–542.
  • Loomis D, Richardson DB, Elliott L. 2019. Quantitative relationships of exposure to chrysotile asbestos and mesothelioma mortality. Am J Ind Med. 62(6):471–477.
  • Lorenzini E, Alessia C, Federica T. 2021. Molecular fingerprints of malignant pleural mesothelioma: not just a matter of genetic alterations. JCM. 10(11):2470.
  • Lynch JR, Ayer HE. 1968. Measurement of asbestos exposure. J Occup Environ Med. 10:21–24.
  • Macarthur AC, Le ND, Fang R, Band PR. 2009. Identification of occupational cancer risk in British Columbia: a population-based case-control study of 2,998 lung cancers by histopathological subtype. Am J Ind Med. 52(3):221–232.
  • Madl AK, Gaffney SH, Balzer JL, Paustenbach DJ. 2009. Airborne asbestos concentrations associated with heavy equipment brake removal. Ann Occup Hyg. 53(8):839–857.
  • Madl AK, Scott LL, Murbach DM, Fehling KA, Finley BL, Paustenbach DJ. 2008. Exposure to chrysotile asbestos associated with unpacking and repacking boxes of automobile brake pads and shoes. Ann Occup Hyg. 52:463–479.
  • Maines R. 2012. The asbestos litigation master narrative: building codes, engineering standards, and "retroactive inculpation". Enterp Soc. 13(4):862–897.
  • Maltoni C, Minardi F, Morisi L. 1982. Pleural mesotheliomas in Sprague-Dawley rats by erionite: first experimental evidence. Environ Res. 29(1):238–244.
  • Mann EL. 1983. Asbestos. In: Lefond SJ, editor. Industrial minerals and rocks. 5th ed. New York: Society Mining Engineers of the American Institute of Mining, Metallurgical, and Petroleum Engineers.
  • Markowitz SB, Levin SM, Miller A, Morabia A. 2013. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med. 188(1):90–96.
  • Matos EL, Vilensky M, Mirabelli D, Boffetta P. 2000. Occupational exposures and lung cancer in Buenos Aires, Argentina. J Occup Environ Med. 42:653–659.
  • Matter of New York City Asbestos Litig., M. D., 483–484 (SUP. CT. NY COUNTY, NY 2015). 2015. (“For all of these reasons, Markowitz's opinions, either individually or collectively, do not establish that asbestos contained in friction products can cause mesothelioma, and as he conceded, he could identify no study to support his proposition that there is an increased risk of contracting mesothelioma from exposure to auto brakes, clutches, or gaskets or that there is an increased risk of mesothelioma from the use of friction products or work on friction materials in the automobile industry … Markowitz not only cited no study to support his opinion, but he also conceded that numerous studies contradict it.”), aff’d, 32 N.Y.3d 1116 (2018).
  • Mcdonald AD, Mcdonald C. 1980. Malignant Mesothelioma in North America. Cancer. 46(7):1650–1656.
  • Mensi C, DE Matteis S, Dallari B, Riboldi L, Bertazzi PA, Consonni D. 2016. Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections. Occup Environ Med. 73(9):607–613.
  • Merlo DF, Stagi E, Fontana V, Consonni D, Gozza C, Garrone E, Bertazzi PA, Pesatori AC. 2010. A historical mortality study among bus drivers and bus maintenance workers exposed to urban air pollutants in the city of Genoa, Italy. Occup Environ Med. 67(9):611–619.
  • Mezie G, Moolgavkar S, Mowat F. 2020. Comment on draft risk evaluation for asbestos for consideration by Science Advisory Committee on Chemicals (SACC). Washington (DC): Comments submitted by Exponent, Inc.
  • Moline J. 2020. Jacqueline Moline, MD, MSc statement on EPA’s draft risk evaluation of asbestos. Hempstead (NY): Comment submitted by The Donald and Barbara Zucker School of Medicine.
  • Moolgavkar SH, Meza R, Turim J. 2009. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control. 20(6):935–944.
  • Moore LL. 1988. Asbestos Exposure Associated with Automotive Brake Repair in Pennsylvania. Am Ind Hyg Assoc J. 49:3.
  • Morabia A, Markowitz S, Garibaldi K, Wynder EL. 1992. Lung cancer and occupation: results of a multicentre case-control study. Occup Environ Med. 49(10):721–727.
  • Mossman BT. 2020. Comments on draft risk evaluation for asbestos. Washington (DC): Department of Pathology and Laboratory Medicine, The University of Vermont, Larner College of Medicine, Burlington, Vermont.
  • Mossman BT, Churg A. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 157(5 Pt 1):1666–1680.
  • Mossman BT, Lippmann M, Hesterberg TW, Kelsey KT, Barchowsky A, Bonner JC. 2011. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B. 14(1–4):76–121.
  • National Academies of Sciences. 2021. The use of systematic review in EPA's toxic substances control act risk evaluations. Washington (DC): The National Academies Press.
  • Niosh NIFOSAH. 2017. Current intelligence bulletin 68. NIOSH chemical carcinogen policy. Publication No. 2017–100. Cincinnati (OH): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, NIOSH.
  • Offermans NS, Vermeulen R, Burdorf A A, Goldbohm RA, Keszei AP, Peters S, Kauppinen T, Kromhout H, Van Den Brandt PA. 2014. Occupational asbestos exposure and risk of oral cavity and pharyngeal cancer in the prospective Netherlands Cohort Study. Scand J Work Environ Health. 40(4):420–427.
  • Oliver LC. 2020. Comments on the toxic substances control act draft risk evaluation for asbestos. Brookline (MA): Comments submitted by Occupational Health Initiatives Inc.
  • OSHA. 1994. 29 CFR Parts 1910, 1915, and 1926. Occupational exposure to asbestos; Final rule. Fed Reg. 59:40964–41162. https://www.osha.gov/laws-regs/federalregister/1994-08-10
  • Paustenbach D. 2020. RE: Paustenbach phone conversation with EPA official.
  • Paustenbach D. 2021. RE: Personal communication with a member of the SACC panel.
  • Paustenbach D, Brew D. 2020. RE: updated comments by Paustenbach on EPA draft risk evaluation for asbestos of March 30, 2020. Washington, DC: Comments Submitted By Paustenbach and Associates.
  • Paustenbach DJ, Finley BL, Lu ET, Brorby GP, Sheehan PJ. 2004. Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 To present): a “state-of-the-art” review. J Toxicol Environ Health B Crit Rev. 7(1):25–80.
  • Paustenbach DJ, Richter RO, Finley BL, Sheehan PJ. 2003. An evaluation of the historical exposures of mechanics to asbestos in brake dust. Appl Occup Environ Hyg. 18(10):786–804.
  • Pavlisko EN, Liu B, Green C, Sporn T, Roggli VL. 2020. Malignant diffuse mesothelioma in women: a study of 354 cases. Am J Surg Pathol. 44(3):293–304.
  • Pierce JS, Ruestow PS, Finley BL. 2016. An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma. Crit Rev Toxicol. 46(7):561–586.
  • Pigg BJ. 1994. The uses of chrysotile. Ann Occup Hyg. 38(4):453–458.
  • Platek SF, Groth DH, Ulrich CE, Stettler LE, Finnell MS, Stoll M. 1985. Chronic inhalation of short asbestos fibers. Fundam Appl Toxicol. 5(2):327–340.
  • Plato N, Tornling G, Hogstedt C, Krantz G. 1995. An index of past asbestos exposure as applied to car and bus mechanics. Ann Occup Hyg. 39(4):441–454.
  • Poole A, Brown RC, Turver CJ, Skidmore JW, Griffiths DM. 1983. In vitro genotoxic activities of fibrous erionite. Br J Cancer. 47(5):697–705.
  • Pooley FD, Mitha R. 1986. Determination and interpretation of the levels of chrysotile asbestos in lung tisue. Biological effects of chrysotile. Accomplishments Oncol. 1:12–18.
  • Pott F. 1978. Some aspects on the dosimetry of the carcinogenic potency of asbesatos and other fibrous susts. Staub – Reinhalt. 38
  • Price B. 2020. Comments on: draft risk evaluation for asbestos - EPA Document # EPA-740-R1-8012, March 2020. Washington (DC): Comment submitted by Price Associates, Inc.
  • Price B, Ware A. 2009. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 39(7):576–588.
  • Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. 2009. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer. 100(7):1175–1183.
  • Reid G. 2015. MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets. J Thorac Dis. 7(6):1031–1040.
  • Reinstein L, Sussman R. 2020. Comments of asbestos disease awareness organization on draft EPA Risk evaluation for asbestos under the toxic substances control act. Redondo Beach (CA): Comment submitted by Asbestos Disease Awareness Organization.
  • Richiardi L, Boffetta P, Simonato L, Forastiere F, Zambon P, Fortes C, Gaborieau V, Merletti F. 2004. Occupational risk factors for lung cancer in men and women: a population-based case-control study in Italy. Cancer Causes Control. 15(3):285–294.
  • Richter RO, Finley BL, Paustenbach DJ, Williams PRD, Sheehan PJ. 2009. An evaluation of short-term exposures of brake mechanics to asbestos during automotive and truck brake cleaning and machining activities. J Expo Sci Environ Epidemiol. 19(5):458–474.
  • Roberts D. 1980a. Allied brake shop. Cincinnatti (OH): National Institute for Occupational Safety and Health.
  • Roberts D. 1980b. Reading brake and alignment service. Reading (OH): National Institute for Occupational Safety and Health.
  • Roberts DR, Zumwalde RD. 1982. Industrial hygeine summary report of asbestos exposure assessment for brake mechanics. Washington (DC): Industrial Hygeine Section - National Institute for Occupational Safety and Health.
  • Rödelsperger K, Jahn H, Brückel B, Manke J, Paur R, Woitowitz HJ. 1986. Asbestos dust exposure during brake repair. Am J Ind Med. 10(1):63–72.
  • Roggli VL, Brody AR. 1984. Changes in numbers and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp Lung Res. 7(2):133–147.
  • Roggli VL, Sporn TA. 2020. Comments on draft risk evaluation for asbestos. Washington (DC): Duke University Medical Center.
  • Roggli V, Oury T, Moffatt E. 1997. Malignant mesothelioma in women. anatomic pathology. Chicago (IL): ASCP Press.
  • Rolland P, Gramond C, Berron H, Ducamp S, Imbernon E, Goldberg M, Brochard P. 2005. Pleural mesothelioma: professions and occupational areas at risk among humans. Institut de Veille Sanitaire. 1–6.
  • Rolland P, Gramond C, Lacourt A, Astoul P, Chamming'S S, Ducamp S, Frenay C, Galateau-Salle F, Ilg AGS, Imbernon E, et al. 2010. Occupations and industries in France at high risk for pleural mesothelioma: a population-based case-control study (1998-2002). Am J Ind Med. 53(12):1207–1219.
  • Rowson DM. 1978. The chrysotile content of the wear debris of brake linings. Wear. 47(2):315–321.
  • Saracci R. 1977. Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction: asbestos and lung cancer. Int J Cancer. 20(3):323–331.
  • Schaapveld M, Aleman BMP, VAN Eggermond AM, Janus CPM, Krol ADG, VAN DER Maazen RWM, Roesink J, Raemaekers JMM, DE Boer JP, Zijlstra JM, et al. 2015. Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma. N Engl J Med. 373(26):2499–2511.
  • Schonfeld SJ, Mccormack V, Rutherford MJ, Schüz J. 2014. Regional variations in German mesothelioma mortality rates: 2000–2010. Cancer Causes Control. 25(5):615–624.
  • Schubauer-Berigan MK, Daniels RD, Bertke SJ, Tseng C-Y, Richardson DB. 2015. Cancer mortality through 2005 among a pooled cohort of U.s. nuclear workers exposed to external ionizing radiation. Radiat Res. 183(6):620–631.
  • Sebastien P, Mcdonald JC, Mcdonald AD, Case B, Harley R. 1989. Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis. Br J Ind Med. 46(3):180–187.
  • Selikof IJ, Hammond EC, Churg J. 1968. Asbestos exposure, smoking, and neoplasia. JAMA. 204:106–112.
  • Selikoff IJ, Hammond EC, Seidman H. 1979. Mortality experience of insulation workers in the United States and Canada, 1943–1976. Ann N Y Acad Sci. 330:91–116.
  • Selikoff IJ, Seidman H, Hammond EC. 1980. Mortality effects of cigarette smoking among amosite asbestos factory workers. J Natl Cancer Inst. 65(3):507–513.
  • Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA. 2017. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 358:j4008.
  • Sheehy JW, Cooper TC, O'Brien DM, Mcglothlin JD, Froehlich PA. 1989. Control of asbestos exposure during brake drum service. Washington (DC): U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health.
  • Sheehy J, Godbey F, Cooper T, Lenihan K, VAN Wagenen H, Mcglothlin J. 1987a. In-depth survey report: control technology for brake drum service operations at Ohio Department of Transportation, Maintenance Facility, Lebanon, Ohio, CT-152-18b. Washington (DC): National Institute for Occupational Safety and Health.
  • Sheehy J, Todd W, Cooper T, VAN Wagenen H. 1987b. In-depth survey report: evaluation of brake drum service controls at Cincinnati Bell Maintenance Facility, Fairfax, Ohio, Report No. CT-152-21B. Washington (DC): National Institute for Occupational Safety and Health.
  • Shukla A, Jung M, Stern M, Fukagawa NK, Taatjes DJ, Sawyer D, VAN Houten B, Mossman BT. 2003. Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. Am J Physiol Lung Cell Mol Physiol. 285(5):L1018–L1025.
  • Spencer JW. 2003. Report of findings: exposure assessment: an evaluation of the contribution of airborne asbestos fibers from the removal and installation of brake and clutch materials from John Deere tractors. Baltimore (MD): Environmental Profiles, Inc.
  • Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, Harlow BL, Benichou J. 1994. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 51(12):804–811.
  • Spirtas R, Keehn R, Wright W, Stark A, Beebe G, Dickson E. 1985. Mesothelioma risk related to occupational or other asbestos exposure: preliminary results from a case control study. Am J Epidemiol. 122:518.
  • Stanton MF. 1973. Some etiological considerations of fiber carcinogenesis. Biological effects of asbestos. Lyon (France): International Agency for Research on Cancer.
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Kent E. 1977. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst. 58:17.
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. 1981. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 67(5):965–975.
  • Swanson GM, Lin CS, Burns PB. 1993. Diversity in the association between occupation and lung cancer among black and white men. Cancer Epidemiol Prev Biomark. 2:313–320.
  • Teschke K, Morgan MS, Checkoway H, Franklin G, Spinelli JJ, van Belle G, Weiss NS. 1997. Mesothelioma surveillance to locate sources of exposure to asbestos. Can J Public Health. 88(3):163–168.
  • Teta MJ, Lau E, Sceurman BK, Wagner ME. 2007. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer. 109(7):1432–1438.
  • Teta MJ, Lesinsohn H, Wister Meigs J, Vidone R, Mowad L, Flannery J. 1983. Mesothelioma in Connecticut, 1955–1977. J Occup Med, 25, 8.
  • Thomsen RW, Riis AH, Flachs EM, Garabrant DH, Bonde JPE, Toft Sorensen H. 2021. Risk of asbestosis, mesothelioma, other lung disease or death among motor vehicle mechanics: a 45-year Danish cohort study. Thorax.
  • Tomasallo CD, Christensen KY, Raymond M, Creswell PD, Anderson HA, Meiman JG. 2018. An occupational legacy: malignant mesothelioma incidence and mortality in Wisconsin. J Occup Environ Med. 60(12):1143–1149.
  • Tomasetti C, Li L, Vogelstein B. 2017. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 355(6331):1330–1334.
  • Tomasetti C, Vogelstein B. 2015. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 347(6217):78–81.
  • Toyooka S, Kishimoto T, Date H. 2008. Advances in the molecular biology of malignant mesothelioma. Acta Med Okayama. 62(1):1–7.
  • Travis LB, Fosså SD, Schonfeld SJ, Mcmaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, et al. 2005. Second cancers among 40 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 97(18):1354–1365.
  • Travis LB, Hauptmann M, Gaul LK, Storm HH, Goldman MB, Nyberg U, Berger E, Janower ML, Hall P, Monson RR, et al. 2003. Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res. 160(6):691–706.
  • Tward JD, Wendland MMM, Shrieve DC, Szabo A, Gaffney DK. 2006. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 107(1):108–115.
  • UNARCO. 2012. Insutape Inventory. CRMC-Marshville-002758.
  • UNARCO. 1954. Specifications on UNARCO Insubestos Felt. CRMC Marshville Files 000444.
  • USGS. 2019. Mineral commodity summaries: asbestos. Washington (DC): USGS.
  • VAN Kaick G, Dalheimer A, Hornik S, Kaul A, Liebermann D, Lührs H, Spiethoff A, Wegener K, Wesch H, Luhrs H. 1999. The German thorotrast study: recent results and assessment of risks. Radiat Res. 152(6 Suppl):S64–S71.
  • Vineis P, Thomas T, Hayes RB, Blot WJ, Mason TJ, Pickle LW, Correa P, Fontham ET, Schoenberg J. 1988. Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer. 42(6):851–856.
  • Wagner JC, Berry G, Skidmore JW, Timbrell V. 1974. The effects of the inhalation of asbestos in rats. Br J Cancer. 29(3):252–269.
  • Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. 1985. Erionite exposure and mesotheliomas in rats. Br J Cancer. 51(5):727–730.
  • Walls MP. 2020. Re: draft Risk Evaluation for Asbestos, EPA-740-R1-8012 (March 2020); for consideration by the Science Advisory Committee on Chemicals. Washington (DC): American Chemistry Counsel (ACC).
  • Wassermann M, Wassermann D, Steinitz R, Katz L, Lemesch C. 1980. Mesothelioma in children. In: Wagner, J. C. (ed.) Biological effects of mineral fibres. Vol. 1. Lyon (France): International Agency for Research on Cancer.
  • Weglarz C, Hawkins E, Davis E. 2020. The EPA’s march to ban asbestos: 2020 draft risk evaluation. Def Couns J. 87(3).
  • Weil S. 1985. Asbestos exposure - brakes and ambient. Internal Memo to Amy Moll. Washington (DC): United States Environmental Protection Agency.
  • Weill D. 2018. Proceedings of the Monticello Conference on Elongate Mineral Particles (EMP). Toxicol Appl Pharmacol. 361:1–2.
  • Weir FW, Tolar G, Meraz LB. 2001. Characterization of vehicular brake service personnel exposure to airborne asbestos and particulate. Appl Occup Environ Hyg. 16(12):1139–1146.
  • Welch LS, Acherman YIZ, Haile E, Sokas RK, Sugarbaker PH. 2005. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health. 11(3):254–258.
  • Williams PRD. 2020. Comments on EPA’s Draft Toxic Substances Control Act (TSCA) risk evaluation for asbestos (EPA-740-R1-8012). Washington (DC): Comment submitted by E Risk Sciences, LLP.
  • Williams RL, Muhlbaier JL. 1982. Asbestos brake emissions. Environ Res. 29(1):70–82.
  • Williams RR, Stegens NL, Goldsmith JR. 1977. Associations of cancer site and type with occupation and industry from the Third National Cancer Survey Interview. J Natl Cancer Inst. 59(4):1147–1185.
  • Woitowitz H-J, Rodelsperger K. 1994. Mesothelioma among car mechanics? Ann Occup Hyg. 38(4):635–638.
  • Wong O. 2001. Malignant Mesothelioma and asbestos exposure among auto mechanics: appraisal of scientific evidence. Regul Toxicol Pharmacol. 34(2):170–177.
  • Yano E, Wang X, Wang M, Qiu H, Wang Z. 2010. Lung cancer mortality from exposure to chrysotile asbestos and smoking: a case-control study within a cohort in China. Occup Environ Med. 67(12):867–871.
  • Yeung P, Patience K, Apthorpe L, Willcocks D. 1999. An Australian study to evaluate worker exposure to chrysotile in the automotive service industry. Appl Occup Environ Hyg. 14(7):449–458.